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of group self-management interventions
for adults with epilepsy
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Abstract
Background: Epilepsy is a serious and costly long-term condition that negatively affects quality of life, especially
if seizures persist on medication. Studies show that people with epilepsy (PWE) want to learn more about the
condition and some educational self-management courses have been trialled internationally. The objectives of
this review were to evaluate research and summarise results on group self-management interventions for PWE.
Methods: We searched Medline and PsycINFO for results published in English between 1995 and 2015. Only
studies evaluating face-to-face, group interventions for adults with epilepsy were included. Heterogeneity in
study outcomes prevented the carrying out of a meta-analysis; however, a Cochrane style review was undertaken.
Results: We found eleven studies, nine of which were randomised controlled trials. There were variable standards
of methodological reporting with some risk of bias. Seven of the studies used quality of life as an outcome, with
four finding statistically significant improvements in mean total score. Two found an improvement in outcome
subscales. One study included some additional semi-qualitative data.
Conclusions: We identified promising trends in the trials reviewed. In particular, there were significant improvements
in quality of life scales and seizure frequency in many of the interventions. However, considerable heterogeneity
of interventions and outcomes made comparison between the studies difficult. Courses that included psychological
interventions and others that had a high number of sessions showed more effect than short educational courses.
Furthermore, the evidence was predominantly from pilot studies with small sample sizes and short follow-up duration.
Further research is needed to better evaluate the role of group self-management interventions in outpatient epilepsy
management.
Keywords: Self-management education, Epilepsy, Patient-education, Quality of life
Background
Epilepsy is a long-term condition characterised by recurrent
seizures, with a prevalence of around 1% in the general
population [1, 2]. Common consequences of living with
epilepsy include driving limitations, detrimental effects on
education, unemployment, and diminished psychological
wellbeing [3]. Stigma, frequency of seizures, and healthcare
experiences also affect quality of life (QoL) in people with
epilepsy (PWE) [4].
Epilepsy has significant financial and social costs.
Direct costs are associated with a high rate of emergency
admission that occurs with poorly-controlled epilepsy
[5]. Emergency service use makes up the majority of
admissions for epilepsy. Among all long-term condi-
tions, epilepsy is the sixth most common cause of emer-
gency admission in the United Kingdom [6, 7]. Reducing
unnecessary emergency admissions is a key factor in
helping to relieve financial pressure on healthcare ser-
vices. Another major social issue is the indirect cost of
epilepsy due to lost employment [8]. The health and
social costs could be reduced and QoL improved via
better outpatient management. However, around 40% of
those diagnosed have poorly-controlled epilepsy and
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continue to have two or more seizures per year, [3] despite
using antiepileptic drugs (AEDs). These figures highlight
missed opportunities for epilepsy self-management.
Management of long-term conditions requires self-
efficacy and empowerment, enabling patients to live as
independently as possible and reducing the need to go
to hospital [9]. For other long-term conditions, strat-
egies for enabling such behaviour have been attempted
within self-management education courses. A diabetes
group intervention used in the United Kingdom, called
DESMOND, is a cost-effective intervention, shown to
improve biopsychosocial outcomes [10–12]. The programme
is structured and can be run over one to two days for six
hours in total [12]. Content is based on social learning
theory [13] and is integrated into standard outpatient
care for diabetes.
Early research evidence from North America [14] and
Germany [15] suggested that group self-management
courses had the potential to have a positive effect on
health outcomes in PWE. The interest in group self-
management for PWE has grown; however, the evidence
base for developing self-management groups as standard
outpatient care for PWE is still small. The objectives of this
review were to evaluate recent research and summarise
results of group self-management interventions for PWE.
This was undertaken in the context that our group was
conducting a trial of group self-management education
intervention in the UK [16].
Methods
Study eligibility criteria
Population
PWE, adults aged 16 or over, without learning disabilities
(due to the markedly different approaches required for
educational programs in these populations [17]).
Intervention
Group self-management interventions were the focus of
this review, irrespective of the study objectives (i.e., educa-
tion, behavioural therapy, or a combination were included).
We were interested in the psychological and social ele-
ments of face-to-face, group self-management courses.
Studies using telemedicine were therefore excluded, as
they are not provided face-to-face in groups.
Comparison
Treatment as usual or waitlist control.
Outcomes of interest
There was particular interest in QoL as this is the out-
come favoured by the National Institute for Health and
Care Excellence (NICE) [18, 19]. However, as there is no
fixed consensus on the best measure for evaluating
group interventions, we also included studies assessing
other outcomes such as seizure frequency, psychological
state, self-efficacy, and knowledge of epilepsy.
Exclusion criteria
Studies reporting trial protocol without results, one-to-
one interventions, web- or telephone-based interventions,
and samples including people with learning disabilities,
children or non-epileptic seizures.
We searched for papers published from 1990 to 2015.
A randomised controlled trial is considered the “gold
standard” research design for evaluating the efficacy of
an intervention; [20] however, we extended search criteria
to include other forms of clinical trial (i.e., controlled out-
comes design).
Search strategy
We conducted electronic searches of the databases Medline
and PsycINFO using the following keywords: epilepsy,
seizures, self-care/self-efficacy, patient education/education
programme, self-management, group intervention/complex
intervention. A manual search of reference lists was per-
formed to identify further relevant studies. For specific
strategies for database searches refer to Appendix 1.
Quality appraisal
All studies were assessed for quality using the CONSORT
guidelines for reporting clinical trials [21]. Studies were
assigned a number between 0 (description absent) and 2
(satisfactory description) according to how fully they
described the four sections: trial design (methodology),
participants (study sample and characteristics), interven-
tions and study outcomes. Appraisal was carried out by
two independent assessors and studies were discussed as a
group to resolve any disagreements. The Cochrane ap-
proach was used to categorise the studies into ‘high’, ‘low’
or ‘unclear’ risk of bias with regard to random sequence
generation and allocation concealment [22]. As it is not
possible to double-blind a group self-management inter-
vention, this was not included in the quality assessment.
Results
Study selection
The first author conducted the initial literature search,
which was repeated by the second author. The initial
Medline search resulted in 42 papers being identified
(Fig. 1). After examining the titles and abstracts, nine
were unrelated and were excluded. Five studies on non-
epileptic seizures (psychogenic seizures and febrile con-
vulsions) were excluded also [23–27]. Five more were
excluded as their participant population consisted of
children (under 16) or patients with learning disabilities.
Of the remaining papers, six were identified as involving
a telephone or web-based intervention and were also ex-
cluded. Finally, some studies were excluded because no
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group intervention was administered. The papers de-
scribed either individual care programmes or trial proto-
cols with no results.
PsycINFO returned 32 results; three new papers were
identified, but none were eligible for inclusion (two pro-
tocols, one telemedicine). Two studies were included
from the manual literature search, resulting in 11 studies
in total.
Search results
Of the 11 studies included with this review (Table 1),
nine were described by their authors as randomised
controlled trials [15, 28–30, 31, 32–35] and the
remaining two as controlled outcome designs [36, 37].
The first study included a matching strategy for allocat-
ing participants to control or treatment group [37]. The
second study used random assignment but did not pro-
vide more specific protocol information [36]. After syn-
thesising review results, we established that due to
outcome heterogeneity a meta-analysis would not be
possible.
All studies focused on the effects of a group interven-
tion in PWE, with one exclusively recruiting women [28]
and another looking at older adults [32]. Most studies
targeted poorly-controlled epilepsy; however, the defin-
ition of ‘poorly-controlled’ varied and four studies did
not specify a minimum seizure frequency.
We assessed 11 studies for quality and risk of bias
(Table 2). For most studies, the participants and outcome
measures were well described. Trial design was the least
well described throughout the 11 studies followed by the
intervention description. Eight of the 11 studies had low
risk of bias for the generation of the sequence allocating
participants to treatment groups. In most study designs
for self-management courses, the participants and facilitators
will be un-blinded. Other research staff, such as those
assessing participants and analysing data should have
remained blinded to minimise bias. The concealment of
group allocation was not described in the majority of
studies.
Facilitators and treatment groups
Interventions were categorised as educational, [15, 28, 29,
33, 34] psychological (e.g. behavioural therapy) [30, 32, 37]
and psychoeducational programmes (i.e. both) [31, 35].
Psychological and psychoeducational interventions were
delivered by psychologists, whereas educational sessions
were delivered by a range of practitioners. In two studies,
[34, 36] instructors’ qualifications were not clearly specified
(e.g. ‘researcher’ or ‘staff ’). In one study, [15] facilitators were
specified in a previous publication to be physicians, nurses,
psychologists, social workers and occupational therapists.
The treatment of the control group varied across the
studies. In six of the studies, [15, 28, 29, 31, 37, 33] con-
trols received treatment as usual (TAU). Additional input
was given to the controls alongside TAU in one study [33]
in the form of two short telephone calls. In two, [30, 32] a
control for attention was offered, for example, supportive
therapy, involving equivalent attention from professionals,
but without any active teaching or advice. Three studies
[34–36] used a waitlist control design and offered inter-
vention materials after follow-up.
Outcomes
The most frequently assessed outcome measure was
QoL, used in seven studies included within this review
[15, 28–30, 31, 35, 37]. The Quality of Life in Epilepsy
questionnaire (QOLIE-31/QOLIE-89) [38, 39] was
Fig. 1 Search tree
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commonly chosen to assess it [28, 29, 31, 35, 37]. Six
studies [15, 28, 30, 32, 34, 37] measured seizure fre-
quency as a marker of control and three assessed
self-efficacy, [31, 35, 37] using the Epilepsy Self-
Efficacy Scale (ESES) [40]. Two studies [33, 35] used a
specific self-management outcome measure called the Epi-
lepsy Self-Management Scale (ESMS) [41]. Different mea-
sures were used to assess psychological symptoms, such as
the Patient Health Questionnaire (PHQ-9) [42]. Compari-
son between the studies was complicated, due to the het-
erogeneity of outcome measures that were used.
Follow-up
The duration of follow-up ranged from one month [33]
to two years [29] with a median follow-up period of six
months. All studies recorded outcome measures at
baseline before the intervention and at the end of
follow-up. Four also took further measures immediately
post-intervention or halfway through the follow-up
period [30, 32, 35, 36].
Overview of findings
Quality of life
Of the seven studies using QoL outcome measures,
three showed no significant difference in total QoL
scores between the intervention and control groups
[15, 29, 31]. Fraser et al. showed a significant improvement
in QOLIE-31 scores eight weeks post-intervention,
but no statistical significance between means after six
months [35].
Two psychological interventions showed an improve-
ment in QoL scores at follow-up. The cognitive behav-
ioural therapy study demonstrated a significant QOLIE-31
score improvement in the intervention group compared
with the control at the end of a three month follow-up
[37]. Emotional Wellbeing was the only subscale that was
significantly increased. In the trial by Lundgren et al [30].
there was a significant improvement in WHOQOL-BREF
score (World Health Organisation Quality of Life Assess-
ment abbreviated version) [43] in the acceptance and
commitment therapy group, compared to supportive ther-
apy at the final one year follow-up. The Satisfaction with
Life Scale (SWLS) [44] score was improved at all three
time points after the intervention.
One education-focused study showed an improvement
in QoL score. The trial by Losada-Camacho et al. found
significant improvement in QOLIE-31 after six months
[28]. The intervention package was offered to women
only, and focused on pharmaceutical aspects of epilepsy
self-management. As one of the co-interventions, partic-
ipants received advice and monitoring at set intervals
from a pharmacist. At six-month follow-up, the total
score increased in the intervention group by 12.45 points
compared with a 2.61 increase in the controls.
Seizure frequency
Six studies measured seizure frequency. Three found
that seizure frequency decreased significantly in the
intervention group compared with controls [28, 30, 32].
However, two studies did not find a significant difference
in seizure frequency post-intervention. Au et al. described
a small improvement in the intervention group but this
was not significant, [37] whereas, Ibinda et al. found a de-
crease in both groups but no difference between them
[34]. One study did not report seizure frequency despite
collecting this data [28]. The reason for this was unclear;
however, it may be due to poor compliance with seizure
diaries as only 37.5% of participants returned them.
Self-management and self-efficacy
Two studies using the ESMS showed promising findings
after group intervention delivery. Aliasgharpour et al.
found a significant difference between the groups post-
intervention with an increase in self-management score
in the intervention group but none in the control [33].
Likewise, Fraser et al. found a treatment effect favouring
the intervention at eight weeks which, although small,
remained significant at the six month follow-up [35].
Three studies used the ESES to measure self-efficacy
[31, 35, 37]. Fraser et al. found a significant treatment
effect in ESES score after eight weeks but this did not
persist at six months. Au et al. found a significant im-
provement in score in the intervention group compared
to control. Findings from Pramuka et al. showed a trend
towards improvement in the intervention group but this
was not significant.
Psychological symptoms
Two of the six studies which used symptom scales indicat-
ing psychological comorbidity showed statistically signifi-
cant improvement [35, 36]. Fraser et al. found a statistical
significant change in PHQ-9 [39] score with reductions
in depressive symptom severity at eight weeks post-
intervention; however, the difference between interven-
tion and control was not statistically significant at six
months. Olley et al. found an improvement in psycho-
logical state compared with controls but, with only two
months follow-up, no long-term benefit was demonstrated
[36]. The others found improvements which were not
significant [28, 31, 32]. In the study by Losada-Camacho
et al. the psychological outcome results were not reported,
[28] nor were they published elsewhere.
Discussion
Quality assessment revealed gaps in the methodological
reporting of many studies, especially regarding trial design.
Risk of bias was assessed and most papers fell into the ‘un-
clear’ category due to insufficient description of treatment
concealment. We paid particular attention to who delivered
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each intervention and how thoroughly this was described.
Information about the role and training of facilitators is
needed in order to replicate an intervention and apply it to
other healthcare settings.
The usefulness of study findings is somewhat dimin-
ished in those that lacked thorough reporting of treatment
fidelity. Most interventions were delivered multiple times,
sometimes by different facilitators; however, only one
study discussed means of ensuring treatment fidelity but
the results were not presented [30]. Group interventions
may not be delivered consistently and without reporting
on measures to prevent deviation, it is uncertain whether
interventions were delivered as planned.
All studies reported significant improvement in the
intervention group compared with controls in at least
one measure. More than half of the studies assessing
QoL found some positive effect from the intervention
but the duration of that effect is varied. Five studies re-
peated the QoL measures at least six months after the
intervention and only two found a sustained significant
improvement [28, 30]. These both consisted of sessions
which were spread out over time, which may be a better
intervention strategy than one-off courses. Fraser et al.
also delivered their intervention over a period of 8 weeks
but were unable to demonstrate a significant effect at
6 month follow-up [35]. They suggested the addition of
a booster course to the programme. It is likely that other
factors may also influence the duration of improvement.
It was difficult to identify mechanisms that make a
group intervention for PWE effective. This is particularly
true of co-interventions, where group effects cannot be
separated out from additional support. Psychological in-
terventions performed well on QoL and seizure fre-
quency (Table 1) [36, 37, 32] although they had very
small sample sizes (n = 17, 27 and 37). This suggests
that including behavioural therapy in self-management
interventions may be important to affect QoL.
Although some studies found positive trends for QoL
improvements from baseline measurements, the scores
were not necessarily statistically different between study
groups. Many were pilot studies with small sample sizes
and may not have had adequate power to detect important
changes. One study that encountered this problem cal-
culated a required sample size of 180 participants but
recruitment difficulties resulted in a final sample of
only 55 [31]. Larger-scale trials are needed to explore
this further.
Another factor that may have contributed to the lack
of significant effect is the use of unsuitable outcomes.
Two studies found improvements only in measures
developed specifically for the trial, despite including a
variety of other outcomes [15, 34]. This suggests that the
existing scales may not be optimal for evaluating effects
of self-management interventions in this setting.
The diversity of outcome measures used across all
studies made comparison difficult. There were five scales
used to assess QoL, of which two were epilepsy-specific.
Four studies did not use any QoL questionnaires al-
though their chosen outcomes (e.g. seizure frequency)
can be assumed to affect QoL. This highlights lack of
consensus on the most appropriate measures for com-
plex interventions in epilepsy.
Only one study used semi-qualitative data in their evalu-
ation, collecting written comments from participants in
an open-ended satisfaction survey [35]. They received
positive comments about the intervention with 47% of re-
spondents mentioning the value of meeting other PWE.
However, response rates were uncertain and there were
no interviews to explore participants’ views. Guidelines
from the Medical Research Council recommend the inclu-
sion of qualitative methods as part of a process evaluation
for complex interventions [45]. In light of this, it would be
useful to collect further qualitative data on how and why
group self-management interventions are beneficial.
The diversity of study settings also complicates interpret-
ation. As trials were conducted across 13 countries with
wide-ranging cultural and socioeconomic backgrounds,
baseline standards of care and health literacy were likely
different. Furthermore, participants in each setting may not
be representative of the wider population. This was particu-
larly relevant in the Seattle-based study which typically
recruited highly educated participants, some of whom were
volunteers, limiting the generalisability of their findings to
other western countries in which health care is provided to
all socio-economic groups [35].
There are several limitations associated with the present
review. We were unable to perform a meta-analysis due to
significant heterogeneity of outcome measures observed
across the studies. Moreover, not all Cochrane review
tools were utilised when evaluating the quality of studies
included. Findings from the review may also be limited
due to biases arising from initial search criteria (i.e., article
language and publication date).
Suggestions for future research
Based on the evidence available to date, it seems that
QoL is rarely affected long term by educational interven-
tions. Thus to have a better chance of affecting QoL,
self-management interventions should include psycho-
logical components. If group self-management education
is to be offered as part of standard outpatient care for
PWE, as DESMOND is for people with diabetes, then
future research should examine the feasibility and cost-
effectiveness of implementation. Although this review
did not specifically search for published articles with
health economics data, we found no discussion of the cost
of implementing self-management education courses for
PWE in the community. This would be valuable in the
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context of similar programmes being implemented in
countries with public healthcare systems.
Conclusions
The studies evaluating group self-management interven-
tions for PWE found encouraging results. There is some
evidence that psychoeducational measures can be deliv-
ered to improve self-management, seizure control, and
QoL in adults with poorly-controlled epilepsy. The
MOSES programme has been offered in German-speaking
countries for over a decade and other countries are inves-
tigating similar interventions [15]. Promising findings,
along with demand from patients for more information
about epilepsy, are indications for continued interest in
group self-management interventions for PWE.
This review illustrates the need for clarity regarding
outcome measures in this field of epilepsy research.
Additionally, large-scale trials of group self-management
interventions, combining quantitative, qualitative, and
cost-effectiveness data, are required in the future.
Appendix 1
Search strategies
Medline (Ovid) search strategy
1. exp. Epilepsy/
2. epilep*
3. seizures
4. exp. Self Care/
5. exp. Self Efficacy/
6. exp. Patient Education as Topic/
7. educational program
8. self-management
9. group intervention
10. complex intervention
11. 1 or 2 or 3
12. Limit 11 to (English language and yr. = “1995 -
Current”)
13. 4 or 5 or 6 or 7 or 8 or 9 or 10
14. Limit 13 to (English language and yr. = “1995 -
Current”)
15.12 and 14
16. Limit 15 to (clinical trial or controlled clinical trial
or pragmatic clinical trial or randomized controlled
trial)
PsycINFO search strategy
1. Exp Epilepsy/
2. epilep*
3. seizures
4. 1 or 2 or 3
5. self-management
6. exp. Self Efficacy/
7. group intervention
8. complex intervention
9. patient education
10. self care
11. educational program*
12. 5 or 6 or 7 or 8 or 9 or 10 or 11
13. 12 and 4
14. limit 13 to (English language and yr. = “1995-
Current”)
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